Biomedical research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Click here to see hierarchical division and subunit overview
Summary of publications:
Publications (original articles or review articles) published in 2021 from OUS - Division of Surgery, Inflammatory Medicine and Transplantation
12 publications found
Laparoscopic versus open extended radical left pancreatectomy for pancreatic ductal adenocarcinoma: an international propensity-score matched study
Surg Endosc (in press)
DOI 10.1016/j.hpb.2017.10.008, PubMed 33398565
Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study
Urol Oncol (in press)
DOI 10.1016/j.urolonc.2020.12.005, PubMed 33397593
Nuclear IL-33 restrains the early conversion of fibroblasts to an extracellular matrix-secreting phenotype
Sci Rep, 11 (1), 108
DOI 10.1038/s41598-020-80509-5, PubMed 33420328
Bedre oversikt over pankreaskreft i Norge
Tidsskr Nor Laegeforen, 141 (1)
DOI 10.4045/tidsskr.20.0869, PubMed 33433104
Living donation - any news on the donor?
Curr Opin Organ Transplant, 26 (1), 85-90
DOI 10.1186/s12882-019-1214-4, PubMed 33278148
Thoracic Epidural Analgesia for Postoperative Pain Management in Liver Transplantation: A 10-year Study on 685 Liver Transplant Recipients
Transplant Direct, 7 (2), e648
DOI 10.1097/TXD.0000000000001101, PubMed 33437863
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Lancet Respir Med, 9 (1), 96-106
DOI 10.1016/S2213-2600(20)30330-1, PubMed 33412120
Impact of baseline clinical and radiological features on outcome of chronic rhinosinusitis in granulomatosis with polyangiitis
Arthritis Res Ther, 23 (1), 18
DOI 10.1186/s13075-020-02401-x, PubMed 33430923
Longevity, clonal relationship, and transcriptional program of celiac disease-specific plasma cells
J Exp Med, 218 (2)
DOI 10.1084/jem.20200852, PubMed 33095260
The first modified Delphi consensus statement on sleeve gastrectomy
Surg Endosc (in press)
DOI 10.1007/s00464-020-08216-w, PubMed 33433676
Artificial intelligence in colonoscopy - Now on the market. What's next?
J Gastroenterol Hepatol, 36 (1), 7-11
DOI 10.1111/jgh.15339, PubMed 33179322
A Risk Model of Admitting Patients With Silent SARS-CoV-2 Infection to Surgery and Development of Severe Postoperative Outcomes and Death: Projections Over 24 Months for 5 Geographical Regions
Ann Surg, 273 (2), 208-216
DOI 10.1038/s41591-020-1083-1, PubMed 33156071